|
1
|
Jemal A, Bray F, Center MM, Ferlay J, Ward
E and Forman D: Global cancer statistics. CA Cancer J Clin.
61:69–90. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Park YS, Jin MY, Kim YJ, Yook JH, Kim BS
and Jang SJ: The global histone modification pattern correlates
with cancer recurrence and overall survival in gastric
adenocarcinoma. Ann Surg Oncol. 15:1968–1976. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Meng CF, Zhu XJ, Peng G and Dai DQ: Role
of histone modifications and DNA methylation in the regulation of
O6-methylguanine-DNA methyltransferase gene expression in human
stomach cancer cells. Cancer Invest. 28:331–339. 2010. View Article : Google Scholar
|
|
4
|
Kim M, Jang HR, Kim JH, et al: Epigenetic
inactivation of protein kinase D1 in gastric cancer and its role in
gastric cancer cell migration and invasion. Carcinogenesis.
29:629–637. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Jung Y, Park J, Bang YJ and Kim TY: Gene
silencing of TSPYL5 mediated by aberrant promoter methylation in
gastric cancers. Lab Invest. 88:153–160. 2008. View Article : Google Scholar
|
|
6
|
Jones PA and Baylin SB: The fundamental
role of epigenetic events in cancer. Nat Rev Genet. 3:415–428.
2002.PubMed/NCBI
|
|
7
|
Ruthenburg AJ, Allis CD and Wysocka J:
Methylation of lysine 4 on histone H3: intricacy of writing and
reading a single epigenetic mark. Mol Cell. 25:15–30. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Fuks F: DNA methylation and histone
modifications: teaming up to silence genes. Curr Opin Genet Dev.
15:490–495. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Kondo Y, Shen L, Cheng AS, et al: Gene
silencing in cancer by histone H3 lysine 27 trimethylation
independent of promoter DNA methylation. Nat Genet. 40:741–750.
2008. View
Article : Google Scholar : PubMed/NCBI
|
|
10
|
Zha L, Wang Z, Tang W, Zhang N, Liao G and
Huang Z: Genome-wide analysis of HMGA2 transcription factor binding
sites by ChIP on chip in gastric carcinoma cells. Mol Cell Biochem.
364:243–251. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Fahrner JA, Eguchi S, Herman JG and Baylin
SB: Dependence of histone modifications and gene expression on DNA
hypermethylation in cancer. Cancer Res. 62:7213–7218.
2002.PubMed/NCBI
|
|
12
|
Cameron EE, Bachman KE, Myöhänen S, Herman
JG and Baylin SB: Synergy of demethylation and histone deacetylase
inhibition in the re-expression of genes silenced in cancer. Nat
Genet. 21:103–107. 1999. View
Article : Google Scholar : PubMed/NCBI
|
|
13
|
Jenuwein T and Allis CD: Translating the
histone code. Science. 293:1074–1080. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Zhang L, Zhong K, Dai Y and Zhou H:
Genome-wide analysis of histone H3 lysine 27 trimethylation by
ChIP-chip in gastric cancer patients. J Gastroenterol. 44:305–312.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Wu J, Wang SH, Potter D, Liu JC, Smith LT,
Wu YZ, Huang TH and Plass C: Diverse histone modifications on
histone 3 lysine 9 and their relation to DNA methylation in
specifying gene silencing. BMC Genomics. 8:1312007. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Miao F, Wu X, Zhang L, Yuan YC, Riggs AD
and Natarajan R: Genome-wide analysis of histone lysine methylation
variations caused by diabetic conditions in human monocytes. J Biol
Chem. 282:13854–13863. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Zhang L, Dai Y, Wang L, Peng W, Zhang Y,
Ou Y and Lu J: CpG array analysis of histone H3 lysine 4
trimethylation in peripheral blood mononuclear cells of uremia
patients. DNA Cell Biol. 30:179–186. 2011. View Article : Google Scholar
|
|
18
|
Gulbins E, Coggeshall KM, Brenner B,
Schlottmann K, Linderkamp O and Lang F: Fas-induced apoptosis is
mediated by activation of a Ras and Rac protein-regulated signaling
pathway. J Biol Chem. 271:26389–26394. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Esteve P, Embade N, Perona R, Jiménez B,
del Peso L, León J, Arends M, Miki T and Lacal JC: Rho-regulated
signals induce apoptosis in vitro and in vivo by a p53-independent,
but Bcl2 dependent pathway. Oncogene. 17:1855–1869. 1998.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Perletti L, Talarico D, Trecca D,
Ronchetti D, Fracchiolla NS, Maiolo AT and Neri A: Identification
of a novel gene, PSD, adjacent to NFKB2/lyt-10, which contains Sec7
and pleckstrin-homology domains. Genomics. 46:251–259. 1997.
View Article : Google Scholar
|
|
21
|
Okada S, Suzuki K, Takaharu K, Noda H,
Kamiyama H, Maeda T, Saito M, Koizumi K, Miyaki Y and Konishi F:
Aberrant methylation of the pleckstrin and Sec7 domain-containing
gene is implicated in ulcerative colitis-associated carcinogenesis
through its inhibitory effect on apoptosis. Int J Oncol.
40:686–694. 2012.
|
|
22
|
Kang H, Cui K and Zhao K: BRG1 controls
the activity of the retinoblastoma protein via regulation of
p21CIP1/WAF1/SDI. Mol Cell Biol. 24:1188–1199. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Zhang HS, Gavin M, Dahiya A, Postigo AA,
Ma D, Luo RX, Harbour JW and Dean DC: Exit from G1 and S phase of
the cell cycle is regulated by repressor complexes containing
HDAC-Rb-hSWI/SNF and Rb-hSWI/SNF. Cell. 101:79–89. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Maitra A, Wistuba II, Washington C,
Virmani AK, Ashfaq R, Milchgrub S, Gazdar AF and Minna JD:
High-resolution chromosome 3p allelotyping of breast carcinomas and
precursor lesions demonstrates frequent loss of heterozygosity and
a discontinuous pattern of allele loss. Am J Pathol. 159:119–130.
2001. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Wistuba II, Gazdar AF and Minna JD:
Molecular genetics of small cell lung carcinoma. Semin Oncol.
28(Suppl 4): 3–13. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
DelBove J, Rosson G, Strobeck M, et al:
Identification of a core member of the SWI/SNF complex,
BAF155/SMARCC1, as a human tumor suppressor gene. Epigenetics.
6:1444–1453. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Xu Z, Liang L, Wang H, Li T and Zhao M:
HCRP1, a novel gene that is downregulated in hepatocellular
carcinoma, encodes a growth-inhibitory protein. Biochem Biophys Res
Commun. 311:1057–1066. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Wittinger M, Vanhara P, El-Gazzar A, et
al: hVps37A status affects prognosis and cetuximab sensitivity in
ovarian cancer. Clin Cancer Res. 17:7816–7827. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Chang X, Li Z, Ma J, Deng P, Zhang S, Zhi
Y, Chen J and Dai D: DNA methylation of NDRG2 in gastric cancer and
its clinical significance. Dig Dis Sci. 58:715–723. 2013.
View Article : Google Scholar
|
|
30
|
Zhi Y, Chen J, Zhang S, Chang X, Ma J and
Dai D: Down-regulation of CXCL12 by DNA hypermethylation and its
involvement in gastric cancer metastatic progression. Dig Dis Sci.
57:650–659. 2012. View Article : Google Scholar
|
